PATENT CLAIM ANALYSIS

Application Number: 15741871
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-03
Patent Classification: ["514", "364000"]

Abstract:
Provided herein are methods for treating multiple sclerosis using (−) 5-((((trans)-2-(4-(benzyloxy)phenyl)cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine, or a pharmaceutically acceptable salt or solvate thereof.

Claim (Index 29):
The method of  claim 22 , wherein the (\u2212) 5-((((trans)-2-(4-(benzyloxy) phenyl) cyclopropyl)amino)methyl)-1,3,4-oxadiazol-2-amine or the pharmaceutically acceptable salt or solvate thereof is administered orally.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.41935
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13812366', '14848649', '15623866', '14057882', '15314851']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.76904003214362
- 35 USC 102 Novelty (BERT): 0.5365341887937861
- Combined Prediction Score: 0.7457894478086367
- Mean Citation Score: 311.917864
- Max Citation Score: 370.7316
- Similarity Product: 282.47567815561297

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test